Masaki Ri

Masaki Ri

UNVERIFIED PROFILE

Are you Masaki Ri?   Register this Author

Register author
Masaki Ri

Masaki Ri

Publications by authors named "Masaki Ri"

Are you Masaki Ri?   Register this Author

65Publications

1030Reads

13Profile Views

Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.

Int J Hematol 2019 Aug 22;110(2):228-236. Epub 2019 May 22.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02669-zDOI Listing
August 2019

Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

Cancer Sci 2019 Aug 11;110(8):2600-2606. Epub 2019 Jul 11.

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.14109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676137PMC
August 2019

Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma.

Cancer Sci 2019 Aug 23. Epub 2019 Aug 23.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.14178DOI Listing
August 2019

[Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma].

Authors:
Masaki Ri

Rinsho Ketsueki 2018;59(10):2162-2168

Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.59.2162DOI Listing
July 2019

Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.

Int J Hematol 2019 Jul 16;110(1):119-123. Epub 2019 Mar 16.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02628-8DOI Listing
July 2019

Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma.

Int J Hematol 2019 Jul 21;110(1):69-76. Epub 2019 May 21.

Division of Blood Transfusion, Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02649-3DOI Listing
July 2019

Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.

Cancer Sci 2018 Aug 27;109(8):2383-2390. Epub 2018 Jun 27.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113433PMC
August 2018

Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.

Liver Int 2017 08 29;37(8):1138-1147. Epub 2017 Jan 29.

Departments of Virology & Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.13349
Publisher Site
http://dx.doi.org/10.1111/liv.13349DOI Listing
August 2017

Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma.

Authors:
Masaki Ri

Int J Hematol 2016 Sep 12;104(3):273-80. Epub 2016 May 12.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2016-0DOI Listing
September 2016

The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.

Int J Hematol 2016 Sep 2;104(3):384-91. Epub 2016 Jun 2.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2033-zDOI Listing
September 2016

Design, Synthesis, and Biological Activity of Isosyringolin A.

Org Lett 2016 05 28;18(9):2312-5. Epub 2016 Apr 28.

Faculty of Pharmaceutical Sciences, Hokkaido University , Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.orglett.6b01053DOI Listing
May 2016

Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapy.

Authors:
Masaki Ri

Rinsho Ketsueki 2016 05;57(5):537-45

Nagoya City University of Medical Science, Department of Medical Oncology & Immunology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.57.537DOI Listing
May 2016

Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.

Int J Hematol 2016 Mar 29;103(3):316-21. Epub 2015 Dec 29.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1925-7DOI Listing
March 2016

Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.

Ann Hematol 2016 Jan 10;95(2):279-85. Epub 2015 Nov 10.

Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2549-yDOI Listing
January 2016

Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Int J Hematol 2015 Nov 4;102(5):569-78. Epub 2015 Sep 4.

Division of Hematology, Department of Internal Medicine, Aichi Medical University, 1, 1 Karimata, Yazako, Nagakute, Aichi, 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1859-0DOI Listing
November 2015

Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.

Int J Hematol 2015 Apr 30;101(4):398-404. Epub 2015 Jan 30.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1750-zDOI Listing
April 2015

Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.

Cancer Res 2014 Dec 30;74(24):7418-29. Epub 2014 Sep 30.

Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-1420DOI Listing
December 2014

Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.

Hum Pathol 2014 Jun 6;45(6):1192-8. Epub 2014 Feb 6.

Department of Anatomic Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.01.017DOI Listing
June 2014

Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.

ChemMedChem 2014 Mar 8;9(3):657-64. Epub 2014 Jan 8.

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Taishogun, Nishitakatsukasa-cho, Kita-ku, Kyoto 603-8334 (Japan); PRESTO (Japan) Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, Saitama 332-0012 (Japan).

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cmdc.201300414
Publisher Site
http://dx.doi.org/10.1002/cmdc.201300414DOI Listing
March 2014

[Myeloma therapy (3) Trends in development of new drugs].

Rinsho Ketsueki 2013 Aug;54(8):715-8

View Article

Download full-text PDF

Source
August 2013

Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.

J Immunol 2013 Jul 3;191(1):135-44. Epub 2013 Jun 3.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1202692DOI Listing
July 2013

Angioimmunoblastic T-cell lymphoma mice model.

Leuk Res 2013 Jan 29;37(1):21-7. Epub 2012 Sep 29.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.09.009DOI Listing
January 2013

RSK2(Ser227) at N-terminal kinase domain is a potential therapeutic target for multiple myeloma.

Mol Cancer Ther 2012 Dec 25;11(12):2600-9. Epub 2012 Sep 25.

Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0605DOI Listing
December 2012

Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.

J Med Chem 2012 Nov 12;55(22):9562-75. Epub 2012 Nov 12.

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Taishogun Nishitakatsukasa-Cho, Kita-ku, Kyoto 403-8334, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm300837yDOI Listing
November 2012

Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.

Cancer Sci 2012 Oct 13;103(10):1764-73. Epub 2012 Aug 13.

Department of Medical Oncology & Immunology, Nagoya City University Graduate School of Medical Sciences, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2012.02371.xDOI Listing
October 2012

Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.

Hum Pathol 2012 Aug 7;43(8):1322-7. Epub 2012 Mar 7.

Department of Pathology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.10.013DOI Listing
August 2012

A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma model.

Cancer Immunol Immunother 2010 Dec 17;59(12):1791-800. Epub 2010 Aug 17.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0905-2DOI Listing
December 2010

Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports.

Int J Hematol 2010 Jun 15;91(5):844-9. Epub 2010 May 15.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-010-0592-y
Publisher Site
http://dx.doi.org/10.1007/s12185-010-0592-yDOI Listing
June 2010

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.

Cancer Immunol Immunother 2009 Aug 2;58(8):1195-206. Epub 2008 Dec 2.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0632-0DOI Listing
August 2009

Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

Int J Cancer 2009 Jul;125(1):212-21

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.24351
Publisher Site
http://dx.doi.org/10.1002/ijc.24351DOI Listing
July 2009

Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1.

Cancer Sci 2009 Feb;100(2):341-8

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2008.01038.xDOI Listing
February 2009

[Histopathological findings of pulmonary complications in 16 patients who received allogeneic hematopoietic stem cell transplants].

Rinsho Ketsueki 2005 Dec;46(12):1273-8

Department of Hematology, Meitetsu Hospital.

View Article

Download full-text PDF

Source
December 2005